Invention Grant
US08771666B2 Ex-vivo treatment of T-cells with IFN-λ 有权
用IFN-λ离体处理T细胞

Ex-vivo treatment of T-cells with IFN-λ
Abstract:
The present invention provides a method of treating Th2-associated diseases and disorders by modulating the expression or secretion of IL-4, IL-5 and IL-13 using interferon lambda (IFN-λ). For Th2-associated diseases and disorders, cells of a patient having a Th2-associated disease or disorder are treated ex vivo, with IFN-λ and returned to the patient. The present invention also provides a method of ex vivo treatment, in conjunction with co-administration of IFN-λ.
Public/Granted literature
Information query
Patent Agency Ranking
0/0